NCT03802656

Brief Summary

This study will determine whether vertebral body tethering is a safe and feasible method of treatment for pediatric idiopathic scoliosis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 14, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

June 24, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2019

Completed
Last Updated

April 12, 2023

Status Verified

April 1, 2023

Enrollment Period

6 months

First QC Date

January 10, 2019

Last Update Submit

April 10, 2023

Conditions

Keywords

ScoliosisIdiopathic ScoliosisAdolescent Idiopathic ScoliosisVertebral Body Tetheringgrowth modulation spinespinejuvenile scoliosis

Outcome Measures

Primary Outcomes (1)

  • Safety: Incidence of Treatment-Emergent Adverse Events

    Intraoperative and post-intervention medical events or signs and symptoms of complications arising after the start of study intervention will be captured. The event description, date of onset, end date, severity, and outcome will be documented. The frequencies, type, body system, severity, and relationship to the study intervention will also be summarized. A distinction will be made between those events which are "device-related" and "non device-related".

    2 years after last subject's device implantation

Secondary Outcomes (2)

  • Feasibility: Incidence of Successfully Implanted Tether Devices

    2 years after last subject's device implantation

  • Efficacy: Comparison of Preoperative and Postoperative Cobb Angle

    2 years after last subject's device implantation

Study Arms (1)

Anterior Vertebral Body Tethering

EXPERIMENTAL

Subjects who will be undergoing the anterior vertebral body tethering surgery.

Device: Anterior Vertebral Body Tethering

Interventions

Vertebral body tethering through anterior thoracoscopic approach under general anesthesia and fluoroscopic guidance.

Anterior Vertebral Body Tethering

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Males or females age 8 to 16 years old at time of enrollment (inclusive)
  • Diagnosis of idiopathic scoliosis
  • Sanders bone age of less than or equal to 4
  • Thoracic or thoracolumbar/lumbar curves of greater than or equal to 35 degrees and less than or equal to 60 degrees from levels T4 through L3
  • Lenke classification of 1, 2, 3, 5, or 6
  • Patient has already been identified for and recommended to have surgical intervention
  • Spina bifida occulta is permitted
  • Spondylolysis or Spondylolisthesis is permitted, as long as it is non-operative, the patient has not had any previous surgery for this, and no surgery is planned in the future
  • Completed standard-of-care procedures as outlined in Section 5

You may not qualify if:

  • Pregnancy (current)
  • Prior spinal or chest surgery
  • MRI abnormalities (including syrinx greater than 4mm, Chiari malformation, or tethered cord)
  • Neuromuscular, thoracogenic, cardiogenic scoliosis, or any other non-idiopathic scoliosis
  • Associated syndrome, including Marfan Disease or Neurofibromatosis
  • Sanders bone age greater than 4
  • Thoracic or thoracolumbar/lumbar curves less than 35 degrees or greater than 60 degrees
  • Compensatory curve greater than 35 degrees without intent to treat surgically
  • Unable or unwilling to firmly commit to returning for required follow-up visits
  • Investigator judgement that the subject/family may not be a candidate for the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ochsner Health System- Jefferson Hwy

New Orleans, Louisiana, 70121, United States

Location

MeSH Terms

Conditions

ScoliosisSpinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Lawrence Haber, MD

    Ochsner Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2019

First Posted

January 14, 2019

Study Start

June 24, 2019

Primary Completion

December 12, 2019

Study Completion

December 12, 2019

Last Updated

April 12, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations